Press release
Liver Cancer Drug Market Size Forecasted To Achieve 4.22 Billion By 2029 With Steady Growth
Liver Cancer Drug
What Is the Liver Cancer Drug Market Size and Projected Growth Rate?
The market for liver cancer medication has seen a swift expansion in the recent past. The market size, which stands at $2.34 billion in 2024, is projected to soar to $2.64 billion in 2025, marking a compound annual growth rate (CAGR) of 12.7%. The growth trajectory during the historic period can be traced back to an increase in liver cancer incidences, a surge in the aging population, amplified global healthcare spending, heightened awareness and screening initiatives, and a growing demand for immunotherapy.
Expectations are high for the liver cancer drug market, as it is slated to witness significant growth in the upcoming years. By 2029, the market is predicted to reach a value of $4.22 billion, with a compound annual growth rate (CAGR) of 12.4%. The factors contributing to this growth during the forecast period are an uptick in clinical trial investments, a surge in the adoption of precision medicine, an upswing in global drug approvals, a climbing incidence of hepatitis, and an increase in research and innovation. The forecast period is going to be characterized by progress in the areas of targeted therapy, immunotherapy drugs, personalized medicine, the assimilation of AI in oncology, and the incorporation of biomarker diagnostics.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24282&type=smp
What Are the Major Segments in the Liver Cancer Drug Market?
The liver cancer drug market covered in this report is segmented -
1) By Type: Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Other Types
2) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Hepatocellular Carcinoma: Targeted Therapy, Immunotherapy, Chemotherapy, Combination Therapy
2) By Cholangio Carcinoma: Targeted Therapy, Chemotherapy, Immunotherapy, Photodynamic Therapy
3) By Hepatoblastoma: Chemotherapy, Targeted Therapy, Immunotherapy, Surgical Adjuvants
4) By Other Types: Chemotherapy, Targeted Therapy, Experimental Or Off-label Therapies, Supportive Care Medications
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24282&type=smp
What Are The Driving Liver Cancer Drug Market Evolution?
The escalation in research and development activities can potentially stimulate the growth of the liver cancer drug market. Research and development represent a systematic process that focuses on the discovery, production, and analysis of new products, technologies, or methods, aiming to enhance knowledge and bring forth ground-breaking solutions to the market. The mounting demand for innovation and technological progression across various industries is giving rise to increased research and development, encouraging companies to make investments in novel products and improvements to maintain a competitive edge. These activities particularly bolster liver cancer drug advancements, facilitating the creation of targeted therapies that enhance treatment efficiency while reducing harm to healthy liver tissue. For example, Cancer Research UK, a cancer research organization based in the United Kingdom, reported that, in September 2024, an investment of $533 million (£399 million) was made in cancer research during the 2023/24 financial year. Of this, $124 million (£93 million) was devoted to research relevant to all cancer kinds, and $112 million (£84 million) was dedicated to rudimentary studies aimed at comprehending cancer's essential biology. Consequently, the escalating research and development activities are fueling the growth of the liver cancer drug market.
Which Firms Dominate The Liver Cancer Drug Market Segments?
Major companies operating in the liver cancer drug market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG, Takeda Pharmaceutical Company Limited, Hetero Drugs Limited, Sun pharma, Eisai Company Limited, Genentech Incorporated, Ipsen Société Anonyme, Cipla Limited, Dr. Reddy's Laboratories Limited, BeiGene Ltd., Exelixis Incorporated, Natco Pharma Limited, MacroGenics Inc.
What Are the Major Trends Shaping the Liver Cancer Drug Market?
Key players in the liver cancer drug market are concentrating on the creation of innovative therapies, like advanced treatment for liver cancer, to increase the accuracy of treatment and patient results. The reference to advanced liver cancer therapy denotes cutting-edge strategies such as immunotherapy, targeted therapy, gene therapy, CAR-T cell therapy, and minimally invasive methods like TACE and ablation. These strategies target improved efficacy and precision in liver cancer treatments. For example, in November 2023, Terumo India, a medical device manufacturer based in India, launched the advanced Balloon-TACE therapy to treat liver cancer in India. The therapy relies on the innovative medical devices - Occlusafe and LifePearl, designed to enhance the precision and efficacy of transcatheter arterial chemoembolization (TACE). This therapy specifically targets hepatocellular carcinoma, the prevalent liver cancer in India, by applying chemotherapy straight to tumors while reducing harm to healthy tissues and retaining liver functionality.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-cancer-drug-global-market-report
Which Is The Largest Region In The Liver Cancer Drug Market?
North America was the largest region in the liver cancer drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Cancer Drug Market?
2. What is the CAGR expected in the Liver Cancer Drug Market?
3. What Are the Key Innovations Transforming the Liver Cancer Drug Industry?
4. Which Region Is Leading the Liver Cancer Drug Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Cancer Drug Market Size Forecasted To Achieve 4.22 Billion By 2029 With Steady Growth here
News-ID: 4060617 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
